These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29745454)

  • 21. [Intravenous clomipramine for depressive disorders].
    Landowski J; Lamparska E; Wichowicz H; Gizińska D; Godlewska B; Wiglusz M
    Psychiatr Pol; 2002; 36(6 Suppl):85-91. PubMed ID: 12647426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in behavior and monoamine laterality following neonatal clomipramine treatment.
    Andersen SL; Dumont NL; Teicher MH
    Dev Psychobiol; 2002 Jul; 41(1):50-7. PubMed ID: 12115290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluvoxamine as effective as clomipramine against symptoms of severe depression: results from a multicentre, double-blind study.
    Zohar J; Keegstra H; Barrelet L
    Hum Psychopharmacol; 2003 Mar; 18(2):113-9. PubMed ID: 12590404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placebo-controlled double-blind clomipramine trial for the treatment of anxiety or fear in beagles during ground transport.
    Frank D; Gauthier A; Bergeron R
    Can Vet J; 2006 Nov; 47(11):1102-8. PubMed ID: 17147141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Augmenting selective serotonin reuptake inhibitors with clomipramine in obsessive-compulsive disorder: benefits and risks.
    Andrade C
    J Clin Psychiatry; 2013 Dec; 74(12):e1128-33. PubMed ID: 24434100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment strategies of obsessive-compulsive disorder and panic disorder/agoraphobia.
    Marazziti D; Carlini M; Dell'Osso L
    Curr Top Med Chem; 2012; 12(4):238-53. PubMed ID: 22204483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of serotonin-selective and classical antidepressants on the auditory P300 cognitive potential.
    d'Ardhuy XL; Boeijinga PH; Renault B; Luthringer R; Rinaudo G; Soufflet L; Toussaint M; Macher J
    Neuropsychobiology; 1999 Nov; 40(4):207-13. PubMed ID: 10559704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of neonatal clomipramine treatment on locomotor activity, anxiety-related behavior and serotonin turnover in Syrian hamsters.
    Yannielli PC; Kargieman L; Gregoretti L; Cardinali DP
    Neuropsychobiology; 1999 May; 39(4):200-6. PubMed ID: 10343185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clomipramine dose-effect study in patients with depression: clinical end points and pharmacokinetics. Danish University Antidepressant Group (DUAG).
    Clin Pharmacol Ther; 1999 Aug; 66(2):152-65. PubMed ID: 10460069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of acute intravenous clomipramine on obsessive-compulsive symptoms and response to chronic treatment.
    Mundo E; Bellodi L; Smeraldi E
    Biol Psychiatry; 1995 Oct; 38(8):525-31. PubMed ID: 8562664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The neonatal treatment with clomipramine decreases sexual motivation and increases estrogen receptors expression in the septum of male rats: Effects of the apomorphine.
    Molina-Jiménez T; Jiménez-Tlapa M; Brianza-Padilla M; Zepeda RC; Hernández-González M; Bonilla-Jaime H
    Pharmacol Biochem Behav; 2019 May; 180():83-91. PubMed ID: 30910666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy and tolerability of clomipramine, pirlindole and escitalopram in the treatment of neurotic level depression].
    Bun'kova KM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):29-32. PubMed ID: 18427538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for an involvement of supraspinal delta- and spinal mu-opioid receptors in the antihyperalgesic effect of chronically administered clomipramine in mononeuropathic rats.
    Marchand F; Ardid D; Chapuy E; Alloui A; Jourdan D; Eschalier A
    J Pharmacol Exp Ther; 2003 Oct; 307(1):268-74. PubMed ID: 12954814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zinc improves clomipramine effects on depressive and locomotor behavior and reverses its oxidative stress in rats.
    Othman H; Ammari M; Lassoued A; Sakly M; Abdelmelek H
    Behav Brain Res; 2019 Nov; 374():112122. PubMed ID: 31376442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous clomipramine in severe and refractory obsessive-compulsive disorder.
    Cordioli AV; Basso de Sousa M; Bochi DB
    J Clin Psychopharmacol; 2003 Dec; 23(6):665-6. PubMed ID: 14624197
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of repeated restraint stress and clomipramine on Na+/K+-ATPase activity and behavior in rats.
    Balk Rde S; Silva MH; Bridi JC; Carvalho NR; Portella Rde L; Dobrachinski F; Amaral GP; Barcelos R; Dias GR; Rocha JB; Barbosa NB; Soares FA
    Int J Dev Neurosci; 2011 Dec; 29(8):909-16. PubMed ID: 21762772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Pigott TA; Seay SM
    J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatitis associated with clomipramine administration in a dog.
    Kook PH; Kranjc A; Dennler M; Glaus TM
    J Small Anim Pract; 2009 Feb; 50(2):95-8. PubMed ID: 19200265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition and possible induction of rat CYP2D after short- and long-term treatment with antidepressants.
    Daniel WA; Haduch A; Wójcikowski J
    J Pharm Pharmacol; 2002 Nov; 54(11):1545-52. PubMed ID: 12495558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developmental emergence of an obsessive-compulsive phenotype and binge behavior in rats.
    Freund N; Thompson BS; Norman KJ; Einhorn P; Andersen SL
    Psychopharmacology (Berl); 2015 Sep; 232(17):3173-81. PubMed ID: 26018530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.